Vicki L. Wheelock, M.D.
Clinical Interests
Dr. Wheelock joined the faculty at UC Davis in 1996 and launched the Movement Disorders
program. She started the Huntington's disease clinic at UC Davis, and the clinic was designated a
Center of Excellence by the Huntington's Disease Society of America (HDSA) in 2001. Dr.
Wheelock also co-directed a satellite program for the surgical treatment of Parkinson's disease
through Kaiser Permanente from 1998-2006 and has extensive experience in Deep Brain
Stimulator therapy. She has also been active with HDSA, serving on the Center Program and
Education Advisory Committee since 2004, and she received the HDSA Patient and Family Care
Award in 2007. A member of the Huntington Study Group (HSG) since 1997, Dr. Wheelock has
served as a site investigator for numerous HSGsponsored trials, and was elected to the Executive
Committee in 2007. Dr. Wheelock has recently formed a collaboration with Dr. Jan Nolta in the
UC Davis Center for Regenerative Medicine with the goal of developing stem cell therapies for
Huntington's disease.
Title
Clinical Professor
Specialty
Neurology
Department
Neurology
Division
Neurology
Address/Phone
Lawrence J. Ellison Ambulatory Care Center, Neurology, 4860 Y St. Suite 0100 Sacramento, CA
95817
Phone: 916-734-3588
Additional Phone
Clinic Phone: 916-734-3588
Physician Referrals: 800-4-UCDAVIS (800-482-3284)
Education
M.D., University of Michigan Medical School, Ann Arbor, Michigan, 1983
B.S., University of Michigan, Ann Arbor, Michigan, 1979
Internships
William Beaumont Hospital, Royal Oak, Michigan, 1983-1984
Residency
University of Southern California, Los Angeles, California, 1984-1987
Board Certifications
American Board of Psychiatry and Neurology, 1990
National Board of Medical Examiners, 1984
Vicki L. Wheelock, M.D.
Professional Memberships
American Academy of Neurology
Dystonia Medical Research Foundation
Huntington Study Group
Huntington’s Disease Society of America
International Tremor Foundation
Movement Disorder Society
Select Recent Publications
Higginson CI, Wheelock V, Levine D, King D, Pappas CTEand Sigvardt KA. Cognitive Deficits in
Essential Tremor Consistent with Frontosubcortical Dysfunction, J Clin Exp Neuropsychol. 2008
Feb 15:1-6.
Higginson CI, Wheelock V, Levine D, King D, Pappas CTEand Sigvardt KA. The clinical
significance of neuropsychological changes following bilateral subthalamic nucleus deep brain
stimulation for Parkinson's disease. J C1in Exp Neuropsychol. 2008 May 19:1-8.
Huntington Study Group TREND-HD Investigators. Randomized controlled trial of ethyleicosapentaenoic acid in Huntington disease: the TREND-HD study. Arch Neurol 2008 Dec;65
(12):1582-9.
Paulsen JS, Hayden M, Stout JCand the PREDICT-HD Investigators. Preparing for clinical trials:
The PREDICT-HDstudy. Arch Neurol 2006;63:883-890
Shoulson I and the Huntington Study Group PHAROS Investigators. At Risk for Huntington
Disease: The PHAROS(Prospective Huntington At Risk Observational Study) Cohort Enrolled. Arch
Neurol 2006;63:991-998.
Wheelock VL, Tempkin T, Marder K, Nance M, Myers R, Zhao H, Kayson E, Orme C, Shoulson I
and the Huntington Study Group. Predictors of nursing home placement in Huntington disease.
Neurology 60:998-1001, 2003.
© 2016 UC Regents